news AI and cloud computing used to develop COVID-19 vaccine 8 April 2020 | By Victoria Rees (Drug Target Review) A potential COVID-19 vaccine has been developed by researchers using AI and cloud computing to prevent the Spike protein from binding to the ACE2 receptor on human cells.
news Novel COVID-19 vaccine shows efficacy in mice 3 April 2020 | By Victoria Rees (Drug Target Review) Researchers have developed a vaccine against the COVID-19 coronavirus which induced the rapid production of antibodies in mice.
news Biotech and academia collaborate on intranasal COVID-19 vaccine development 2 April 2020 | By Hannah Balfour (Drug Target Review) The University of Alabama at Birmingham (UAB) will run the pre-clinical trials of Altimmune’s intranasal COVID-19 vaccine candidate, AdCOVID.
news COVID-19 update: funding for treatments and vaccines 1 April 2020 | By Victoria Rees (Drug Target Review) Drug Target Review rounds up the latest announcements regarding funding for research into COVID-19 treatments and vaccines.
news Johnson & Johnson identifies lead COVID-19 vaccine candidate 31 March 2020 | By Victoria Rees (Drug Target Review) A lead COVID-19 vaccine candidate has been selected by Johnson & Johnson, after demonstrating promise in pre-clinical testing.
news Researchers to screen compound library for antiviral drugs to combat COVID-19 23 March 2020 | By Victoria Rees (Drug Target Review) Scripps Research has announced it will screen over 14,000 compounds to see if any present significant activity against COVID-19, for use in a therapeutic.
news Understanding of COVID-19 infections in children will aid treatment development, say researchers 20 March 2020 | By Victoria Rees (Drug Target Review) A statement from scientists has highlighted that improving the understanding of COVID-19 infections in children will help researchers to develop better treatments.
news Coronavirus update: recent developments in vaccine research 27 February 2020 | By Hannah Balfour (Drug Target Review) Drug Target Review’s round-up of the latest developments in 2019 novel coronavirus (COVID-19 or SARS-CoV-2) therapeutics and vaccines.
news CEPI announces three programmes to develop coronavirus vaccine 27 January 2020 | By Victoria Rees (Drug Target Review) The CEPI has announced three respective projects with Inovio, the University of Queensland and Moderna, to develop a vaccine for the novel coronavirus, nCoV-2019.